You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

Børge Diderichsen

Former Vice President of Corporate Research Affairs at Novo Nordisk A/S
Relationship Science aggregates deep and verified information on over 6 million influential decision makers and the over 1.5 million organizations with which they are associated. From this data, we create a "business social graph" that highlights who knows whom. Here are Børge Diderichsen's strongest connections.

People Most Closely Connected to Børge Diderichsen

Click the names below to expand relationship details.
Mike Rulis
Senior Vice President, Corporate Affairs at Novo Nordisk A/S
Michael Shalmi
Managing Director, Principal Investments at Novo Holding A/S
Karina Sørensen
Former Investor Relations Coordinator at Novo Nordisk A/S
Jørgen Rønnow
General Counsel NOVO Finance & Operations at Novo Holding A/S
Eddie Williams
Senior Vice President of BioPharmaceuticals at Novo Nordisk A/S
Kasper Veje
Associate Director IR, North America at Novo Nordisk A/S
Kristine Kruse Zeij
Former PA/Media Relations Coordinator at Novo Nordisk A/S
Janos Kodra
Principal Scientist at Novo Nordisk A/S
Carsten Worsøe
Principal Scientist at Novo Nordisk A/S
James F. Tripp
Chief Operating Officer & Head of Global Clinical Operations at Tiziana Life Sciences Plc
Per Toft Valstorp
Former President, Medical Systems Division at Novo Nordisk A/S
Jerzy Gruhn
Executive Vice President at Novo Nordisk North America, Inc.
Lise Kingo
Associate Professor-Medical Faculty at Vrije Universiteit Amsterdam
Kåre Schultz
President & Chief Executive Officer at Teva Pharmaceutical Industries Ltd.
Thorkil Kastberg
Former Chief Financial Officer at Novo Holding A/S
Lars R. Sørensen
Former President & Chief Executive Officer at Novo Nordisk A/S
Robert Frederick Caspari
Former Vice President & General Manager-BioPharmaceuticals at Novo Nordisk A/S
Thomas Knittel
Chief Medical Officer at Modus Therapeutics AB
176 more connections are available with a RelSci Professional subscription.